STAGE IIIB CERVICAL CANCER FIGO 2018
Clinical trials for STAGE IIIB CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE IIIB CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink cervical cancer before standard treatment
Disease control Recruiting nowThis study tests whether giving an extra round of chemotherapy and immunotherapy (pembrolizumab) before the usual chemoradiation can help people with high-risk, locally advanced cervical cancer live longer without the disease getting worse. About 336 participants will be randomly…
Matched conditions: STAGE IIIB CERVICAL CANCER FIGO 2018
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New asian registry aims to improve cervical cancer radiation treatment
Knowledge-focused Recruiting nowThis study is a registry that will collect information from 1,000 women with cervical cancer across Asia who are receiving a type of internal radiation called brachytherapy. The goal is to understand how this treatment is currently used in different Asian countries and to see how…
Matched conditions: STAGE IIIB CERVICAL CANCER FIGO 2018
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC